Generating synthetic cohorts of real-world patients with metastatic breast cancer to accelerate collaboration

被引：0
|
作者：
Batlle, Marta [1 ]
Sanglier, Thibaut [2 ]
Labaki, Chris [3 ]
Bakouny, Ziad [3 ]
Braun, David A. [4 ]
Bouquet, Fanny [1 ]
Joyce, Maureen Ann [5 ]
Martin, Miguel Valero [1 ]
Xie, Wanling [3 ]
Tolaney, Sara M. [6 ]
Choueiri, Toni K. [3 ]
机构：
[1] F Hoffmann La Roche, Basel, Switzerland
[2] F Hoffmann La Roche Ltd, Basel, Switzerland
[3] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA
[4] Yale Sch Med, Yale Canc Ctr, New Haven, CT USA
[5] Genentech Inc, San Francisco, CA USA
[6] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
874
引用
收藏
页码：408 / 409
页数：2
相关论文
共 50 条
  • [1] Eligibility of real-world patients with metastatic breast cancer for clinical trials
    Batra, Atul
    Kong, Shiying
    Cheung, Winson Y.
    BREAST, 2020, 54 : 171 - 178
  • [2] Eligibility of real-world patients with metastatic breast cancer in clinical trials
    Batra, A.
    Kong, S.
    Rigo, R.
    Cheung, W.
    ANNALS OF ONCOLOGY, 2020, 31 : S70 - S70
  • [3] Outcome in Patients with Metastatic Breast Cancer Treated with Eribulin: A Real-world Cohort
    Rush, H.
    Khan, M.
    Li, S.
    Agorastos, A.
    Kristeleit, H.
    CLINICAL ONCOLOGY, 2018, 30 (06) : E46 - E46
  • [4] Safety and efficacy of eribulin for "real-world" older patients with metastatic breast cancer
    de Nonneville, Alexandre
    Sabatier, Renaud
    Goncalves, Anthony
    Extra, Jean-Marc
    Tarpin, Carole
    Launay, Simon
    Tassy, Louis
    Viens, Patrice
    Rousseau, Frederique
    JOURNAL OF GERIATRIC ONCOLOGY, 2018, 9 (03) : 281 - 283
  • [5] Real-world treatment in patients with HER2+metastatic breast cancer
    Colomer, R.
    Hall, P.
    Szkultecka-Debek, M.
    Bondi, R. C.
    Flinois, A.
    Auziere, S.
    Le Cleac'h, J. Y.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (01) : 197 - 205
  • [6] Real-world pharmacokinetics and pharmacodynamics of everolimus in metastatic breast cancer
    Masahide Fukudo
    Kei Ishibashi
    Masahiro Kitada
    Investigational New Drugs, 2021, 39 : 1707 - 1715
  • [7] Real-world activity of sacituzumab govitecan for metastatic breast cancer
    Morganti, S.
    Kusmick, R.
    Hughes, M. E.
    Braso-Maristany, F.
    Smith, K.
    Tarantino, P.
    Vega Leon, M. D. R.
    Grinda, T.
    Pardo, F.
    Dvir, K.
    Suggs, G.
    Buck, S.
    Skeffington, M.
    Garrido-Castro, A. C.
    Parsons, H.
    Sammons, S.
    Prat, A.
    Lin, N.
    Tolaney, S. M.
    Giordano, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S382 - S382
  • [8] Real-world pharmacokinetics and pharmacodynamics of everolimus in metastatic breast cancer
    Fukudo, Masahide
    Ishibashi, Kei
    Kitada, Masahiro
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (06) : 1707 - 1715
  • [9] Real-world experience of abemaciclib for adjuvant and metastatic breast cancer
    Drowne, Taylor
    Armgardt, Emily
    Svoboda, Alison
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2025, 31 (01) : 141 - 146
  • [10] Commercial next generation sequencing in a real-world cohort of patients with metastatic breast cancer
    Taneja, Kamil
    Cohen, Jules A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345